These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 35769627)
1. The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer's Disease. Shenoy A; Banerjee M; Upadhya A; Bagwe-Parab S; Kaur G Front Behav Neurosci; 2022; 16():861155. PubMed ID: 35769627 [TBL] [Abstract][Full Text] [Related]
2. Zebrafish Experimental Animal Models for AD: A Comprehensive Review. Sande R; Godad A; Doshi G Curr Rev Clin Exp Pharmacol; 2024; 19(4):295-311. PubMed ID: 38284707 [TBL] [Abstract][Full Text] [Related]
4. Zebrafish as a Promising Tool for Modeling Neurotoxin-Induced Alzheimer's Disease. Thawkar BS; Kaur G Neurotox Res; 2021 Jun; 39(3):949-965. PubMed ID: 33687726 [TBL] [Abstract][Full Text] [Related]
5. Can zebrafish be used as animal model to study Alzheimer's disease? Santana S; Rico EP; Burgos JS Am J Neurodegener Dis; 2012; 1(1):32-48. PubMed ID: 23383380 [TBL] [Abstract][Full Text] [Related]
6. GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease. Nava-Mesa MO; Jiménez-Díaz L; Yajeya J; Navarro-Lopez JD Front Cell Neurosci; 2014; 8():167. PubMed ID: 24987334 [TBL] [Abstract][Full Text] [Related]
7. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
11. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease. Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271 [TBL] [Abstract][Full Text] [Related]
15. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics. Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754 [TBL] [Abstract][Full Text] [Related]
16. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]